Premium
Metabolism‐Activated Multitargeting (MAMUT): An Innovative Multitargeting Approach to Drug Design and Development
Author(s) -
Mátyus Péter,
Chai Christina L. L.
Publication year - 2016
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201500406
Subject(s) - adme , drug , pharmacology , drug development , chemistry , pharmacokinetics , medicine
Multitargeting is a valuable concept in drug design for the development of effective drugs for the treatment of multifactorial diseases. This concept has most frequently been realized by incorporating two or more pharmacophores into a single hybrid molecule. Many such hybrids, due to the increased molecular size, exhibit unfavorable physicochemical properties leading to adverse effects and/or an inappropriate ADME (absorption, distribution, metabolism, and excretion) profile. To avoid this limitation and achieve additional therapeutic benefits, here we describe a novel multitargeting strategy based on the synergistic effects of a parent drug and its active metabolite(s). The concept of metabolism‐activated multitargeting (MAMUT) is illustrated using a number of examples.